abstract |
The present invention relates to novel carbocyclic compounds of formula (I) and pharmaceutically acceptable salts thereof, which are active as modulators of the retinoid-related oropharyngeal receptor gamma (RORγt), wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R a , R b , n, m and p are as defined in the present invention. Such compounds are useful for the prevention, inhibition or inhibition of the activity of RORγt and are useful for the treatment of RORγt mediated diseases, diseases, syndromes or conditions such as pain, inflammation, COPD, asthma, rheumatoid arthritis, colitis, multiple sclerosis, . ≪ / RTI > (I) |